Additionally, paclitaxel can increase C225’s anti-angiogenic and tumor cell metastasis capabilities by downregulating the expression of basic fibroblast growth factor, vascular endothelial growth factor (VEGF), IL-8, and MMP-9. Here, VEGFA is linked to neoplasm.